We titrate slowly to improve comfort and sustainability
Our healthcare providers engage in comprehensive discussions with each candidate, taking into account their medical history, current health conditions, and weight loss goals
There are varieties of studies that confirm this conclusion
Together, GLP-1R, GIPR, and GCGR agonists are expected to see more clinical trial evidence to prove their efficacy and safety in treating obese patients
Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes
To schedule a medical weight loss visit, book online, check insurance, or call 212-457-1722